Metraipolis › archive › dc_f920d8325cfa
Qili Qiangxin ameliorates chronic heart failure: a randomized clinical trial of biomarkers, inflammation, and cardiac outcomes — Europe PMC PMID:41098835
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41098835
- DOI
- 10.3389/fphar.2025.1605944
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T16:46:59.962Z
- SHA-256 of the archived text
90568f1ffecb887331f5e261bfb40df98761eae92c0ce1299fe22df73eb98194- Stable URL of this page
https://metraipolis.com/documento/dc_f920d8325cfa
How to cite
Qili Qiangxin ameliorates chronic heart failure: a randomized clinical trial of biomarkers, inflammation, and cardiac outcomes — Europe PMC PMID:41098835 — Europe PMC (en), https://europepmc.org/article/MED/41098835 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f920d8325cfa (Metraipolis archive dc_f920d8325cfa, sha256 90568f1ffecb887331f5e261bfb40df98761eae92c0ce1299fe22df73eb98194)
BibTeX
@misc{dcf920d8325cfa,
title = {Qili Qiangxin ameliorates chronic heart failure: a randomized clinical trial of biomarkers, inflammation, and cardiac outcomes — Europe PMC PMID:41098835},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41098835},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f920d8325cfa; sha256 90568f1ffecb887331f5e261bfb40df98761eae92c0ce1299fe22df73eb98194},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41098835. Agents can read the archived copy with the MCP tool read_document.